Novel 1-(2-aminopyrazin-3-yl)methyl-2-thioureas as potent inhibitors of mitogen-activated protein kinase-activated protein kinase 2 (MK-2)

被引:17
|
作者
Lin, Songnian [1 ]
Lombardo, Matthew [1 ]
Malkani, Sunita [1 ]
Hale, Jeffrey J. [1 ]
Mills, Sander G. [1 ]
Chapman, Kevin [1 ]
Thompson, James E. [1 ]
Zhang, Wen Xiao [1 ]
Wang, Ruixiu [1 ]
Cubbon, Rose M. [1 ]
O'Neill, Edward A. [1 ]
Luell, Silvi [1 ]
Carballo-Jane, Ester [1 ]
Yang, Lihu [1 ]
机构
[1] Merck Res Labs, Rahway, NJ 07065 USA
关键词
MAPKAP kinase 2; MK-2; TNF alpha; Inflammation; Rheumatoid arthritis; Aminopyrazine; Thiourea; RHEUMATOID-ARTHRITIS;
D O I
10.1016/j.bmcl.2009.04.088
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Novel 1-(2-aminopyrazin-3-yl)methyl-2-thioureas are described as inhibitors of mitogen-activated protein kinase-activated protein kinase 2 (MK-2). These compounds demonstrate potent in vitro activity against the enzyme with IC50 values as low as 15 nM, and suppress expression of TNF alpha in THP-1 cells and in vivo in an acute inflammation model in mice. The synthesis, structure-activity relationship (SAR), and biological evaluation of these compounds are discussed. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3238 / 3242
页数:5
相关论文
共 50 条
  • [21] The MAP kinase-activated protein kinase 2 (MK2) contributes to the Shiga toxin-induced inflammatory response
    Saenz, Jose B.
    Li, Jinmei
    Haslam, David B.
    CELLULAR MICROBIOLOGY, 2010, 12 (04) : 516 - 529
  • [22] Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 (MAPKAP-K2) as an Antiinflammatory Target: Discovery and in Vivo Activity of Selective Pyrazolo(1,5-a)pyrimidine Inhibitors Using a Focused Library and Structure-Based Optimization Approach
    Kosugi, Tomomi
    Mitchell, Dale R.
    Fujino, Aiko
    Imai, Minoru
    Kambe, Mika
    Kobayashi, Shinji
    Makino, Hiroaki
    Matsueda, Yohei
    Oue, Yasuhiro
    Komatsu, Kanji
    Imaizumi, Keiichiro
    Sakai, Yuri
    Sugiura, Satoshi
    Takenouchi, Osami
    Unoki, Gen
    Yamakoshi, Yuko
    Cunliffe, Vicky
    Frearson, Julie
    Gordon, Richard
    Harris, C. John
    Kalloo-Hosein, Heidi
    Le, Joelle
    Patel, Gita
    Simpson, Donald J.
    Sherborne, Brad
    Thomas, Peter S.
    Suzuki, Naotaka
    Takimoto-Kamimura, Midori
    Kataoka, Ken-ichiro
    JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (15) : 6700 - 6715
  • [23] Mitogen-activated protein kinase-activated protein kinase 2 regulates tumor necrosis factor-induced interleukin-6 expression via human antigen R
    Xu Jin
    Su Xin
    Shi Jia-xin
    Sun He
    Wu Ting
    Shi Yi
    CHINESE MEDICAL JOURNAL, 2013, 126 (22) : 4322 - 4326
  • [24] Induction of prostaglandin endoperoxide synthase 2 by mitogen-activated protein kinase cascades
    McGinty, A
    Foschi, M
    Chang, YWE
    Han, JH
    Dunn, MJ
    Sorokin, A
    BIOCHEMICAL JOURNAL, 2000, 352 : 419 - 424
  • [25] Distinct Functions of the Mitogen-activated Protein Kinase-activated Protein (MAPKAP) Kinases MK2 and MK3 MK2 MEDIATES LIPOPOLYSACCHARIDE-INDUCED SIGNAL TRANSDUCERS AND ACTIVATORS OF TRANSCRIPTION 3 (STAT3) ACTIVATION BY PREVENTING NEGATIVE REGULATORY EFFECTS OF MK3
    Ehlting, Christian
    Ronkina, Natalia
    Boehmer, Oliver
    Albrecht, Ute
    Bode, Konrad A.
    Lang, Karl S.
    Kotlyarov, Alexey
    Radzioch, Danuta
    Gaestel, Matthias
    Haeussinger, Dieter
    Bode, Johannes G.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (27) : 24113 - 24124
  • [26] Revisiting p38 Mitogen-Activated Protein Kinases (MAPK) in Inflammatory Arthritis: A Narrative of the Emergence of MAPK-Activated Protein Kinase Inhibitors (MK2i)
    Ganguly, Payal
    Macleod, Tom
    Wong, Chi
    Harland, Mark
    Mcgonagle, Dennis
    PHARMACEUTICALS, 2023, 16 (09)
  • [27] Differential Effects of p38 Mitogen-Activated Protein Kinase and Cyclooxygenase 2 Inhibitors in a Model of Cardiovascular Disease
    Willette, Robert N.
    Eybye, Marianne E.
    Olzinski, Alan R.
    Behm, David J.
    Aiyar, Nambi
    Maniscalco, Kristeen
    Bentley, Ross G.
    Coatney, Robert W.
    Zhao, Shufang
    Westfall, Timothy D.
    Doe, Chris P.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2009, 330 (03) : 964 - 970
  • [28] Association of Common Genetic Variants in Mitogen-activated Protein Kinase Kinase Kinase Kinase 4 with Type 2 Diabetes Mellitus in a Chinese Han Population
    Li, Ting-Ting
    Qiao, Hong
    Tong, Hui-Xin
    Zhuang, Tian-Wei
    Wang, Tong-Tong
    CHINESE MEDICAL JOURNAL, 2016, 129 (10) : 1179 - 1184
  • [29] MiR-20a-5p facilitates cartilage repair in osteoarthritis via suppressing mitogen-activated protein kinase kinase kinase 2
    Liu, Jiazhi
    Tang, Guo
    Liu, Wenjun
    Zhou, Yi
    Fan, Cunyi
    Zhang, Wei
    BIOENGINEERED, 2022, 13 (05) : 13801 - 13814
  • [30] 1,7-Naphthyridine 1-Oxides as Novel Potent and Selective Inhibitors of p38 Mitogen Activated Protein Kinase
    Lumeras, Wenceslao
    Vidal, Laura
    Vidal, Bernat
    Balague, Cristina
    Orellana, Adelina
    Maldonado, Monica
    Dominguez, Maria
    Segarra, Victor
    Caturla, Francisco
    JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (22) : 7899 - 7910